G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn… Read more
G Medical Innovations Holdings Ltd (GMVDF) - Total Assets
Latest total assets as of March 2023: $4.83 Million USD
Based on the latest financial reports, G Medical Innovations Holdings Ltd (GMVDF) holds total assets worth $4.83 Million USD as of March 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
G Medical Innovations Holdings Ltd - Total Assets Trend (2015–2022)
This chart illustrates how G Medical Innovations Holdings Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
G Medical Innovations Holdings Ltd - Asset Composition Analysis
Current Asset Composition (December 2022)
G Medical Innovations Holdings Ltd's total assets of $4.83 Million consist of 41.3% current assets and 58.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.1% |
| Accounts Receivable | $944.00K | 19.6% |
| Inventory | $292.00K | 6.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2015–2022)
This chart illustrates how G Medical Innovations Holdings Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: G Medical Innovations Holdings Ltd's current assets represent 41.3% of total assets in 2022, a decrease from 68.0% in 2015.
- Cash Position: Cash and equivalents constituted 6.1% of total assets in 2022, down from 38.5% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 19.6% of total assets.
G Medical Innovations Holdings Ltd Competitors by Total Assets
Key competitors of G Medical Innovations Holdings Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
G Medical Innovations Holdings Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - G Medical Innovations Holdings Ltd generates 0.92x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - G Medical Innovations Holdings Ltd is currently not profitable relative to its asset base.
G Medical Innovations Holdings Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.22 | 1.03 | 4.60 |
| Quick Ratio | 0.19 | 0.99 | 4.60 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-7.12 Million | $ 270.00K | $ 9.49 Million |
G Medical Innovations Holdings Ltd - Advanced Valuation Insights
This section examines the relationship between G Medical Innovations Holdings Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -54.1% |
| Total Assets | $4.83 Million |
| Market Capitalization | $1.07K USD |
Valuation Analysis
Below Book Valuation: The market values G Medical Innovations Holdings Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: G Medical Innovations Holdings Ltd's assets decreased by 54.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for G Medical Innovations Holdings Ltd (2015–2022)
The table below shows the annual total assets of G Medical Innovations Holdings Ltd from 2015 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $4.83 Million | -54.12% |
| 2021-12-31 | $10.52 Million | +92.97% |
| 2020-12-31 | $5.45 Million | -37.86% |
| 2019-12-31 | $8.77 Million | -38.13% |
| 2018-12-31 | $14.18 Million | -34.07% |
| 2017-12-31 | $21.50 Million | +134.91% |
| 2016-12-31 | $9.15 Million | +7402.60% |
| 2015-12-31 | $122.00K | -- |